primaxin
merck sharp & dohme (new zealand) limited - cilastatin sodium 571mg equivalent to 500 mg cilastatin acid. (includes 4.6% overage).; imipenem monohydrate 560mg equivalent to 500 mg imipenem. (includes 4.6% overage).; - powder for infusion - 500mg/500mg - active: cilastatin sodium 571mg equivalent to 500 mg cilastatin acid. (includes 4.6% overage). imipenem monohydrate 560mg equivalent to 500 mg imipenem. (includes 4.6% overage). excipient: sodium bicarbonate
saizen 8
pharmacy retailing (nz) ltd t/a healthcare logistics - somatropin 8.8mg ((includes 0.8 mg overfill)) - injection with diluent - 8 mg - active: somatropin 8.8mg ((includes 0.8 mg overfill)) excipient: phosphoric acid sodium hydroxide sucrose metacresol water for injection - saizen is indicated for: 1. growth failure in children due to human growth hormone deficiency. 2. growth failure in girls with gonadal dysgenesis (turner syndrome), confirmed by chromosomal analysis. 3.saizen is indicated for replacement therapy in adults with pronounced growth hormone deficiency as diagnosed in 2 different dynamic tests for growth hormone deficiency and defined by peak gh concentrations of less than 2.5 nanogram/ml. adults must also fulfil the following criteria: childhood onset: patients who were diagnosed as growth hormone deficient during childhood, must be retested and their growth hormone deficiency confirmed before replacement therapy with saizen is started. adult onset: patients must have growth hormone deficiency as a result of hypothalamic or pituitary disease and at least one other hormone deficiency diagnosed (except for prolactin) and adequate replacement therapy instituted, before replacement therapy using growth hormone may begin. 4. growth disturbance (growth retardation) in pre-pubertal children due to chronic renal insufficiency (cri).
structolipid 20%
fresenius kabi new zealand limited - structured triglycerides 200 g/l (64:36 ratio of long chain:medium chain triglycerides); ; - emulsion for infusion - 20% w/v - active: structured triglycerides 200 g/l (64:36 ratio of long chain:medium chain triglycerides) excipient: egg lecithin glycerol nitrogen sodium hydroxide water for injection
nutriflex lipid peri emulsion for infusion
b braun melsungen ag carl-braun-strasse 1, d34212 melsungen, germany - calcium chloride, dihydrate, phenylalanine, potassium acetate, histidine, arginine, aspartic acid, threonine, triglycerides medium, chain, valine, zinc acetate, glucose, glutamic acid, glycine, methionine, isoleucine, tryptophan, lysine, magnesium acetate, serine, proline, sodium acetate, trihydrate, sodium chloride, sodium dihydrogen, phosphate dihydrate, sodium hydroxide, soya oil - emulsion for infusion - calcium chloride dihydrate 0.353 g/l phenylalanine 2.81 g/l potassium acetate 2.354 g/l histidine 1 g/l arginine 2.16 g/l aspartic acid 1.2 g/l alanine 3.88 g/l threonine 1.46 g/l triglycerides medium chain 20 g/l valine 2.08 g/l zinc acetate dihydrate 5.3 g/l glucose 64 g/l glutamic acid 2.8 g/l glycine 1.32 g/l methionine 1.57 g/l isoleucine 1.87 g/l l-tryptophan 0.46 g/l lysine 1.81 g/l magnesium acetate 0.515 g/l serine 2.4 g/l leucine 2.5 g/l proline 2.72 g/l sodium acetate trihydrate 0.435 g/l sodium chloride 0.865 g/l sodium dihydrogen phosphate dihydrate 0.936 g/l sodium hydroxide 0.64 g/l soya oil 20 g/l - blood substitutes and perfusion solutions
survanta
abbvie ltd vanwall business park, vanwall road, maidenhead, berkshire, sl6 4ub, united kingdom - free fatty, acids, phospholipids, triglycerides, protein - suspension for intratracheal use - free fatty acids phospholipids 25 mg/ml triglycerides protein - other respiratory system products
oberon
bayer new zealand limited - spiromesifen - suspension concentrate - spiromesifen 240 g/litre - insecticide - insecticides
luna privilege
bayer new zealand limited - fluopyram - suspension concentrate - fluopyram 500 g/litre - fungicide - fungicide
alion
bayer new zealand limited - indaziflam - suspension concentrate - indaziflam 500 g/litre - herbicide - herbicide
smoflipid (lipid emulsion) 20% emulsion for intravenous infusion 250 ml bag
fresenius kabi australia pty ltd - olive oil, quantity: 50 g; fish oil - rich in omega-3 acids, quantity: 30 g; medium chain triglycerides, quantity: 60 g; soya oil, quantity: 60 g - injection, intravenous infusion - excipient ingredients: glycerol; sodium oleate; dl-alpha-tocopherol; water for injections; egg lecithin; sodium hydroxide - supply of energy and essential fatty acids to patients, as part of a parenteral nutrition regimen, when oral or enteral nutrition is impossible, insufficient or contra-indicated.
smoflipid (lipid emulsion) 20% emulsion for intravenous infusion 100 ml bag
fresenius kabi australia pty ltd - olive oil, quantity: 50 g; fish oil - rich in omega-3 acids, quantity: 30 g; medium chain triglycerides, quantity: 60 g; soya oil, quantity: 60 g - injection, intravenous infusion - excipient ingredients: glycerol; sodium oleate; dl-alpha-tocopherol; water for injections; egg lecithin; sodium hydroxide - supply of energy and essential fatty acids to patients, as part of a parenteral nutrition regimen, when oral or enteral nutrition is impossible, insufficient or contra-indicated.